Home » Topics » Regulatory

Regulatory
RSS

SF-1019 approved in Malaysia

Aug. 13, 2008

FDA approves Cleviprex for hypertension when oral therapy is not feasible

Aug. 5, 2008

European Commission approves Schering-Plough's Bridion

July 30, 2008

Health Canada grants approval to Santhera's Catena in Friedreich's ataxia

July 25, 2008

Jerini receives European approval for Firazyr for hereditary angioedema

July 16, 2008

Tredaptive approved in E.U. for dyslipidemia and primary hypercholesterolemia

July 14, 2008

Health Canada grants marketing authorization to Basilea's Zeftera for cSSSI

July 2, 2008

German approval for Oralair Grasses

June 30, 2008

FDA approves Sirion's NDA for Durezol in postoperative ocular inflammation and pain

June 27, 2008

European Commission approves Roche's shortened Pegasys regimen for HCV

June 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...